Tesamorelin + Ipamorelin 11mg / 6mg
Peptide blend • Lyophilized • Not for human or veterinary use
Tesamorelin + Ipamorelin is a dual-peptide research blend studied in controlled laboratory settings for its
potential relevance to growth hormone signaling pathways, pituitary response models,
and metabolic research applications. Tesamorelin is commonly evaluated for its role as a
growth hormone–releasing hormone analog, while Ipamorelin is investigated for selective ghrelin receptor-related
signaling in peptide research models.
In research environments, this combination is often explored for its interaction with GH/IGF-1 axis markers,
body composition signaling models, and broader recovery- and endocrine-associated pathways.
Investigators may examine how these compounds perform together under structured experimental conditions involving
peptide receptor activity, anabolic signaling, and metabolic regulation.
- Dual-peptide blend studied in growth hormone and pituitary signaling research
- Tesamorelin investigated in GHRH analog research models
- Ipamorelin explored for selective ghrelin receptor-related signaling pathways
- Evaluated in metabolic, recovery, and body composition laboratory studies
Reconstitution should be performed using sterile technique under controlled laboratory conditions.
